reports
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering ...
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the closing of its previ...
- Jan Frederik Slijkerman
KPN on track for a strong FY25/Strong competition not denting its perf...
This morning, KPN presented good 2Q25 results, although the equity market seems to have been a bit disappointed by KPN's cash generation in 1H25. Nevertheless, we take it as a positive that KPN has raised its FY25 outlook and remain constructive on its notes. The KPN notes look somewhat attractive compared to some notes of Orange.
- Michiel Declercq
KPN Good commercial momentum, raises outlook following one off IPR tai...
KPN reported a good set of 2Q25 results, with adj. service revenues up 3.7% to € 1339m (kbcse: € 1325m, css: € 1329m). The strong performance was largely driven by B2B, as well a strong commercial momentum in broadband and mobile net adds. While the 6.4% adj. EBITDAal increase to € 670m came in comfortably above our expectations (kbcse: € 658m), we want to highlight that the Adj. EBITDAal was positively impacted by a € 9m tailwind related to IPR claims. These claims are expected to have an addit...
- Olfa Taamallah
- Yan Derocles
EQNR EQUINOR ASA
RNO RENAULT SA
KPN ROYAL KPN NV
TKA TELEKOM AUSTRIA AG
HO THALES SA
LONN LONZA GROUP AG
GLE SOCIETE GENERALE S.A. CLASS A
RAND RANDSTAD NV
ALO ALSTOM SA
ASM ASM INTERNATIONAL N.V.
GAS NATURGY ENERGY GROUP S.A.
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
UCG UNICREDIT S.P.A.
IBE IBERDROLA SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
VACN VAT GROUP AG
SAP SAP SE
BG BAWAG GROUP AG
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AM DASSAULT AVIATION
STMN STRAUMANN HOLDING AG
- Olfa Taamallah
- Yan Derocles
EQNR EQUINOR ASA
RNO RENAULT SA
KPN ROYAL KPN NV
TKA TELEKOM AUSTRIA AG
HO THALES SA
LONN LONZA GROUP AG
GLE SOCIETE GENERALE S.A. CLASS A
RAND RANDSTAD NV
ALO ALSTOM SA
ASM ASM INTERNATIONAL N.V.
GAS NATURGY ENERGY GROUP S.A.
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
UCG UNICREDIT S.P.A.
IBE IBERDROLA SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
VACN VAT GROUP AG
SAP SAP SE
BG BAWAG GROUP AG
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AM DASSAULT AVIATION
STMN STRAUMANN HOLDING AG
- Konrad Zomer
- Lynn Hautekeete
Eurocommercial Properties Megastore sale of EUR 14.1m above fair value
Yesterday Eurocommercial sold its recently developed EKO megastore for EUR 14.1m. The store is located as a standalone unit next to its Grand Samarkand shopping Centre (Sweden). It is part of the strategy to focus solely on shopping centres. The extension was completed in 1Q25 and let to EKO via a 10y lease. The development had a YoC of slightly above 8.0%. The exit yield is significantly lower at 6.3% which is above the latest reported fair value. This signals an ongoing undervaluation of the p...
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
- ING Helpdesk
Benelux Morning Notes
ASM International: 2Q25 Results; Positive tone, weak orders. CM.com: 1H25 results; disappointing performance, guidance downgrade. Gimv: Gimv fuels Hemink's sustainable expansion. KPN: Solid 2Q25, guidance raised largely on €25m IPR claim benefit. Philips: 2Q25 Preview; improvement needed. Randstad: 2Q25 in line; outlook touch below; FX spoils the party but operational leverage story is unfolding. Sofina: Newsletter #16. Universal Music Group: EU opens in-depth investigation into Downtown ...
- Jacob Mekhael
Pharvaris Raises $ 175m in gross proceeds via public offering
Pharvaris announced the pricing of an upsized public offering of 8,250,000 ordinary shares at a price of $ 20 per share (13.49% discount to previous close), and to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $ 19.99 per pre-funded warrant for gross proceeds of approx. $ 175m. We expect the net proceeds to extend Pharvaris' cash runway to mid-2027 (KBCSe) from 2H26, and will be used for R&D as well as commercialisation preparations in the US. We update our ...
- Hilde Van Boxstael
- Jacob Mekhael
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
- Konrad Zomer
- Martin Marandon-Carlhian
- Stephane Houri
KPN delivers a strong quarter; full-year 2025 outlook raised
KPN delivers a strong quarter; full-year 2025 outlook raised Continued Group service revenue growth (+3.7% y-on-y), driven by all segments Consumer service revenues increased 1.3% y-on-ySolid commercial momentum in Consumer broadband (+13k) and postpaid (+37k)Business service revenue growth continues at a high level (+5.7% y-on-y), driven by all divisionsAdj. EBITDA AL increased +6.4% y-on-y in Q2 2025, of which +1.4% IPR benefit and +1.0% Althio contributionH1 Free Cash Flow at € 309m, progressing according to planLeading the Dutch fiber market, now covering two-thirds of the NetherlandsFu...
- Martin Marandon-Carlhian
- Stephane Houri
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of...
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20...
Pharvaris Announces Proposed Public Offering of Ordinary Shares
Pharvaris Announces Proposed Public Offering of Ordinary Shares ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today that it intends to offer and sell $150,000,000 of ordinary shares in an underwritten public offering. All shares in the offering are to be sold b...
ASM reports second quarter 2025 results
ASM reports second quarter 2025 results Almere, The Netherlands July 22, 2025, 6 p.m. CET Solid Q2 results against a backdrop of continued mixed market conditions ASM International N.V. (Euronext Amsterdam: ASM) today reports its Q2 2025 results (unaudited). Financial highlights € million Q2 2024 Q1 2025 Q2 2025 New orders 755.4 834.2 702.5 yoy change % at constant currencies 56% 14% (4%) Revenue 706.1 839.2 835.6 yoy change % as reported 6% 31% 18% ...
- Hilde Van Boxstael
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Wim Hoste
KPN reports on progress of € 250m share buyback
KPN reports on progress of € 250m share buyback KPN has repurchased 1,533,000 KPN ordinary shares in the period from 14 July to 18 July 2025. The shares were repurchased at an average price of € 4.09 per share for a total consideration of € 6.3m. These repurchases are part of the € 250m share buyback started on 25 February 2025 and reflect KPN's commitment to structurally return additional capital to its shareholders. The total number of ordinary shares repurchased until 18 July 2025 is 57,170,738 for a total consideration of € 228.9m. Transaction details of the share buyback are availabl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.